Pulse Biosciences' IPO

Pulse Biosciences raised a round of funding on May 18, 2016. Investors include Public.

Pulse Biosciences, formerly Electroblate, is a development-stage medical device company using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling or NPES. NPES is a local a…

Articles about Pulse Biosciences' IPO: